Global Gastrointestinal Stromal Tumor (GIST) Drug Professional Survey Report 2023, Forecast to 2028
Global Gastrointestinal Stromal Tumor (GIST) Drug Professional Survey Report 2023, Forecast to 2028
The Gastrointestinal Stromal Tumor (GIST) Drug study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
is a tumor in the small intestine or stomach. Symptoms include nausea, vomiting, difficulty swallowing, weight loss, abdomen pain, bleeding, and black stools. Treatment for GIST include medications, surgery, and chemotherapy.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Gastrointestinal Stromal Tumor (GIST) Drug industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
Stomach
Small Intestine
Others
Market Segment by Product Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
Finally, the report provides detailed profile and data information analysis of leading company.
Novartis
Bayer Aktiengesellschaft
Sun Pharmaceutical
Pfizer
NATCO Pharma
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Gastrointestinal Stromal Tumor (GIST) Drug consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Gastrointestinal Stromal Tumor (GIST) Drug market by identifying its various subsegments.
3.Focuses on the key global Gastrointestinal Stromal Tumor (GIST) Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Gastrointestinal Stromal Tumor (GIST) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Gastrointestinal Stromal Tumor (GIST) Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Gastrointestinal Stromal Tumor (GIST) Drug Professional Survey Report Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
2.1.1 Stomach
2.1.2 Small Intestine
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Clinics
2.2.3 Specialized Cancer Treatment Centers
2.2.4 Other End Users
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Comparison by Regions (2018-2028)
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2028)
2.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2018-2028)
2.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2018-2028)
2.3.4 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2018-2028)
2.3.5 South America Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2018-2028)
2.3.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Gastrointestinal Stromal Tumor (GIST) Drug Industry Impact
2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Gastrointestinal Stromal Tumor (GIST) Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share
3.5 Top 10 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
3.7 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Industry Key Manufacturers
4.1 Novartis
4.1.1 Company Details
4.1.2 Novartis Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
4.1.3 Novartis Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 Novartis News
4.2 Bayer Aktiengesellschaft
4.2.1 Company Details
4.2.2 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
4.2.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 Bayer Aktiengesellschaft News
4.3 Sun Pharmaceutical
4.3.1 Company Details
4.3.2 Sun Pharmaceutical Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
4.3.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 Sun Pharmaceutical News
4.4 Pfizer
4.4.1 Company Details
4.4.2 Pfizer Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
4.4.3 Pfizer Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Pfizer News
4.5 NATCO Pharma
4.5.1 Company Details
4.5.2 NATCO Pharma Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
4.5.3 NATCO Pharma Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 NATCO Pharma News
5 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Categorized by Regions
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Sales and Market Share by Regions
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Regions (2018-2023)
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Regions (2018-2023)
5.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
5.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
5.4 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
5.5 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
5.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
6 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Categorized by Countries
6.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Countries
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
6.1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
6.1.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
6.1.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
6.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) by Manufacturers
6.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2018-2023)
6.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
7 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Categorized by Countries
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Countries
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
7.1.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.1.4 UK Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.1.5 France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.1.6 Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.1.7 Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.1.8 Spain Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) by Manufacturers
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2018-2023)
7.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
8 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Categorized by Countries
8.1 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
8.1.2 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
8.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.1.4 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.1.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.1.6 Australia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.1.7 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.1.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
8.2 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) by Manufacturers
8.3 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2018-2023)
8.4 Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
9 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Categorized by Countries
9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Countries
9.1.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
9.1.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
9.1.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
9.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2018-2023)
9.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
10 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Categorized by Countries
10.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
10.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
10.1.3 GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
10.1.4 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
10.1.5 Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
10.1.6 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
10.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type
10.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
11 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Sales and Market Share by Type (2018-2023)
11.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Market Share by Type (2018-2023)
11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2018-2023)
11.2 Stomach Sales Growth Rate and Price
11.2.1 Global Stomach Sales Growth Rate (2018-2023)
11.2.2 Global Stomach Price (2018-2023)
11.3 Small Intestine Sales Growth Rate and Price
11.3.1 Global Small Intestine Sales Growth Rate (2018-2023)
11.3.2 Global Small Intestine Price (2018-2023)
11.4 Others Sales Growth Rate and Price
11.4.1 Global Others Sales Growth Rate (2018-2023)
11.4.2 Global Others Price (2018-2023)
12 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Application
12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
12.2 Hospitals Sales Growth Rate (2018-2023)
12.3 Clinics Sales Growth Rate (2018-2023)
12.4 Specialized Cancer Treatment Centers Sales Growth Rate (2018-2023)
12.5 Other End Users Sales Growth Rate (2018-2023)
13 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast
13.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Sales and Growth Rate (2023-2028)
13.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Regions (2023-2028)
13.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
13.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
13.2.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
13.2.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
13.2.5 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
13.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Type (2023-2028)
13.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028)
13.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2023-2028)
13.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Application (2023-2028)
13.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028)
13.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2023-2028)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Gastrointestinal Stromal Tumor (GIST) Drug Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Gastrointestinal Stromal Tumor (GIST) Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
Figure Global Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2022
Figure Stomach Picture
Figure Small Intestine Picture
Figure Others Picture
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Volume) by Application
Figure Hospitals Picture
Figure Clinics Picture
Figure Specialized Cancer Treatment Centers Picture
Figure Other End Users Picture
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Comparison by Regions (M USD) 2018-2028
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million US$) (2018-2028)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) Growth Rate (2018-2028)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) Growth Rate (2018-2028)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) Growth Rate (2018-2028)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) Growth Rate (2018-2028)
Figure Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) Growth Rate (2018-2028)
Table Business Impact Assessment - Covid-19
Table Market Trends and Gastrointestinal Stromal Tumor (GIST) Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturer in 2022
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2022
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2022
Figure Top 10 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2022
Table Date of Key Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
Table Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table Mergers & Acquisitions Planning
Table Novartis Company Profile
Table Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification of Novartis
Table Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2018-2023
Table Novartis Main Business
Table Novartis Recent Development
Table Bayer Aktiengesellschaft Company Profile
Table Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification of Bayer Aktiengesellschaft
Table Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer Aktiengesellschaft 2018-2023
Table Bayer Aktiengesellschaft Main Business
Table Bayer Aktiengesellschaft Recent Development
Table Sun Pharmaceutical Company Profile
Table Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification of Sun Pharmaceutical
Table Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical 2018-2023
Table Sun Pharmaceutical Main Business
Table Sun Pharmaceutical Recent Development
Table Pfizer Company Profile
Table Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification of Pfizer
Table Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2018-2023
Table Pfizer Main Business
Table Pfizer Recent Development
Table NATCO Pharma Company Profile
Table Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification of NATCO Pharma
Table Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of NATCO Pharma 2018-2023
Table NATCO Pharma Main Business
Table NATCO Pharma Recent Development
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Regions (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Regions in 2022
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2022
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2018-2023)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2022
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2018-2023)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2022
Figure United States Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2022)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2022
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2018-2023)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2018-2023)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2022
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2018-2023)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2022
Figure Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure UK Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Spain Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2022)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2022
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2018-2023)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2018-2023)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2022
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2018-2023)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2022
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Australia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2022)
Figure Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2022
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table Asia-pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2018-2023)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2018-2023)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2020
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2018-2023)
Figure South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2020
Figure Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2018-2023)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume) by Countries (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries (2018-2023)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Countries in 2020
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Countries (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries (2018-2023)
Figure Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Countries in 2020
Figure GCC Countries Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Figure South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2022
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type in 2020
Figure Global Stomach Sales Growth Rate (2018-2023)
Figure Global Stomach Price (2018-2023)
Figure Global Small Intestine Sales Growth Rate (2018-2023)
Figure Global Small Intestine Price (2018-2023)
Figure Global Others Sales Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2022
Figure Global Hospitals Sales Growth Rate (2018-2023)
Figure Global Clinics Sales Growth Rate (2018-2023)
Figure Global Specialized Cancer Treatment Centers Sales Growth Rate (2018-2023)
Figure Global Other End Users Sales Growth Rate (2018-2023)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2023-2028)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Regions (2018-2023)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
Figure Europe Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
Figure Asia-Pacific Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
Figure South America Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
Figure Middle East & Africa Sales Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2023-2028)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Ra
Research Methodology:
Gastrointestinal Stromal Tumor (GIST) Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|